Who offers compounded tirzepatide 10mg least expensively

1. What the price landscape looks like: big spread, many players

Reporting shows a very wide price range for compounded tirzepatide: OrderlyMeds advertises “as little as $166/month” ^[1]; other price surveys and telehealth vendors commonly list monthly costs between roughly $199 and $599 for higher-dose vials or subscription plans ^{[2] [3] [4]}. Aggregators and “cheapest” guides likewise put typical telehealth/compound subscription prices in the $200–$400 band but note outliers on both ends ^{[6] [7]}.

2. Who in these sources appears cheapest on paper

Among the named providers in the collected material, OrderlyMeds is cited with the lowest explicit monthly figure — “as little as $166/month” ^[1]. Other specific named offerings show higher advertised figures: PlushCare’s preferred-pharmacy compounded tirzepatide lists $599 for two vials (7.5mg and 10mg options) ^[3], while some telehealth/compounding combos and price guides list starting prices around $199–$249 ^{[2] [4]}.

3. Legal and regulatory limits that change the playing field

Multiple sources warn compounding tirzepatide is not FDA-approved and that U.S. regulators have restricted or directed compounding of these products. SingleCare reports the FDA directed compounding pharmacies to stop producing tirzepatide (and semaglutide) in 2025, and says compounded versions “are technically no longer available in the U.S.” ^[5]. NutritionNC and other pieces explain the FDA ended grace periods in mid‑2025, which limited the legal ability of compounding pharmacies to make exact-copy tirzepatide once shortages ended ^[8].

4. Why “cheapest” may not be the best or even available option

Price alone ignores three critical issues noted across reporting: safety/quality differences because compounded tirzepatide is not FDA‑reviewed ^{[3] [8] [4]}; potential legal/unavailability problems after FDA directives ^{[5] [8]}; and hidden or recurring fees (membership, onboarding, or refill timing) that raise effective cost ^{[4] [2]}. VaccineAlliance and other guides explicitly caution that extremely low prices (under ~$200) should prompt scrutiny ^[4].

5. Brand self-pay programs that change the comparison

If your goal is the lowest legal, FDA‑approved route, manufacturers’ self-pay options can undercut some compounded prices. PharmacyTimes describes LillyDirect’s Zepbound Self Pay program that reduces 7.5 mg and 10 mg vial prices to $499 (first‑fill offers as low as $499, with other Self Pay pricing reported around $349–$499 in some summaries) — a brand, FDA‑approved product at a fixed price and without compounding risks ^[9]. That can be cheaper or comparable to many compounded offers once regulatory restrictions and safety trade‑offs are considered ^{[9] [3]}.

6. How to evaluate providers beyond sticker price

The reporting suggests checking: whether the product is FDA‑approved or compounded ^{[3] [8]}; stated pharmacy accreditation and USP compounding standards ^{[6] [8]}; total monthly cost including membership/refill fees ^[4]; and current legal status — because directives to stop compounding affect availability and pricing ^[5]. Price guides recommend skepticism toward very low offers and recommend verifying licensing and quality claims ^{[4] [8]}.

7. Bottom line and recommended next steps

If you are simply asking “who offers 10 mg compounded tirzepatide least expensively” in the cited material, OrderlyMeds is the lowest explicit monthly figure shown at $166/month ^[1]. But given multiple sources’ warnings that compounded tirzepatide is not FDA‑approved and that compounding was limited or halted in 2025 ^{[3] [8] [5]}, a practical next step is to verify current legal availability and compare manufacturer self‑pay (LillyDirect/Zepbound) pricing versus any compounding vendor while checking accreditation and total out‑of‑pocket cost ^{[9] [6] [4]}. Available sources do not mention current, up‑to‑the‑minute licensing status of each compounding pharmacy beyond the general FDA directives and marketplace reports ^{[5] [8]}.